← Back to Search

Peer Navigation + Kidney Transplant Fast Track for Improving Access to Kidney Transplants in Minority Populations (AKT-MP Trial)

N/A
Recruiting
Led By Larissa Myaskovsky, PhD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Greater than or equal to 18 years of age
Mentally competent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

AKT-MP Trial Summary

This trial will compare two approaches to help Hispanic/Latino and American Indian patients overcome barriers to completing transplant evaluation and receiving a kidney transplant.

Who is the study for?
This trial is for adults over 18 with kidney disease, specifically Hispanic/Latino and American Indian patients at the University of New Mexico. They must be mentally competent and not currently waitlisted at another center or have had a previous kidney transplant. Pregnant women, children under 18, incarcerated individuals, those with recent non-skin cancer or cognitive impairments are excluded.Check my eligibility
What is being tested?
The study compares two methods to help overcome barriers to getting a kidney transplant: a streamlined evaluation process (KTFT) and peer-assisted support (PN). Participants will be randomly assigned to one of these approaches to see which is more effective and cost-efficient in aiding them through the transplant evaluation process.See study design
What are the potential side effects?
Since this trial focuses on evaluating processes rather than medical treatments, traditional side effects associated with medications are not applicable. However, participants may experience stress or emotional impacts related to navigating the transplantation process.

AKT-MP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am mentally capable of making my own decisions.

AKT-MP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of KT evaluation completion
Secondary outcome measures
KT ambivalence
Patient Reported Quality of Life

AKT-MP Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2Experimental Treatment1 Intervention
PN
Group II: Arm 1Experimental Treatment1 Intervention
KTFT

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
371 Previous Clinical Trials
3,528,502 Total Patients Enrolled
Case Western Reserve UniversityOTHER
299 Previous Clinical Trials
259,696 Total Patients Enrolled
University of Massachusetts, AmherstOTHER
77 Previous Clinical Trials
467,194 Total Patients Enrolled

Media Library

Kidney Transplant Fast Track (KTFT) Clinical Trial Eligibility Overview. Trial Name: NCT04615819 — N/A
Kidney Disease Research Study Groups: Arm 1, Arm 2
Kidney Disease Clinical Trial 2023: Kidney Transplant Fast Track (KTFT) Highlights & Side Effects. Trial Name: NCT04615819 — N/A
Kidney Transplant Fast Track (KTFT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04615819 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical experiment currently recruiting volunteers?

"Clinicaltrials.gov is reporting that this clinical trial, which was originally launched on the 11th of January 2022 and last modified on the 24th of same month, presently has open enrollment for eligible patients."

Answered by AI

What is the target enrollment for this clinical experiment?

"Affirmative, clinicaltrials.gov displays that this research is actively seeking participants. This trial was initially uploaded on 11th January 2022 and edited most recently on 24th January 2022. 398 subjects must be enrolled from one medical site for the study to continue."

Answered by AI
~223 spots leftby Dec 2026